Correction to: Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial (Lancet Haematol (2017) 4(6) (e258–e271) (S2352302617300777) (10.1016/S2352-3026(17)30077-7));Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): A single-centre, parallel-group, open-label, randomised trial

The Lancet Haematology

Volumn 4, Issue 6, 2017, Pages e258-e271

  Innerhofer, Petra ^a   Fries, Dietmar ^a   Mittermayr, Markus ^a   Innerhofer, Nicole ^a   von Langen, Daniel ^a   Hell, Tobias ^b   Gruber, Gottfried ^a   Schmid, Stefan ^a   Friesenecker, Barbara ^a   Lorenz, Ingo H ^a   Ströhle, Mathias ^a   Rastner, Verena ^a   Trübsbach, Susanne ^a   Raab, Helmut ^a   Treml, Benedikt ^a   Wally, Dieter ^a   Treichl, Benjamin ^a   Mayr, Agnes ^a   Kranewitter, Christof ^a   Oswald, Elgar ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR CONCENTRATE; FIBRIN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; LACTIC ACID; PROTHROMBIN COMPLEX; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID; BLOOD CLOTTING FACTOR;

ADULT; AGED; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CONTROLLED STUDY; DRUG EFFICACY; ECHOGRAPHY; ERYTHROCYTE CONCENTRATE; FEMALE; HEMOFILTRATION; HOSPITALIZATION; HUMAN; INJURY; INJURY SCALE; LEUKOCYTE TRANSFUSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; VENOUS THROMBOEMBOLISM; VERY ELDERLY; ADOLESCENT; COMPLICATION; MIDDLE AGED; PLASMA; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION FACTORS; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLASMA; TREATMENT OUTCOME; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 85020599903     PISSN: None     EISSN: 23523026     Source Type: Journal    
DOI: 10.1016/S2352-3026(17)30084-4     Document Type: Erratum

References (28)

1. Davenport, R, Brohi, K, Causes of trauma-induced coagulopathy. Curr Opin Anaesthesiol 29 (2016), 212–229.
2. Rossaint, R, Bouillon, B, Cerny, V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care, 20, 2016, 100.
3. Tauber, H, Innerhofer, P, Breitkopf, R, et al. Prevalence and impact of abnormal ROTEM® assays in severe blunt trauma: results of the ‘Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study’. Br J Anaesth 107 (2011), 378–387.
4. Schöchl, H, Cotton, B, Inaba, K, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care, 15, 2011, R265.
5. Nienaber, U, Innerhofer, P, Westermann, et al. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 42 (2011), 697–701.
6. Schöchl, H, Nienaber, U, Hofer, G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care, 14, 2010, R55.
7. Schöchl, H, Nienaber, U, Maegele, M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care, 15, 2011, R83.
8. Innerhofer, P, Westermann, I, Tauber, H, et al. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 44 (2013), 209–216.
9. Kozek-Langenecker, S, Sørensen, B, Hess, JR, Spahn, DR, Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care, 15, 2011, R239.
10. Dunbar, NM, Chandler, WL, Thrombin generation in trauma patients. Transfusion 49 (2009), 2652–2660.
11. Kashuk, JL, Moore, EE, Sawyer, M, et al. A primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 252 (2010), 434–442.
12. Hagemo, JS, Christiaans, SC, Stanworth, SJ, et al. Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study. Crit Care, 19, 2015, 97.
13. Inaba, K, Branco, BC, Rhee, P, et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 210 (2010), 957–965.
14. Patel, SV, Kidane, B, Klingel, M, Parry, N, Risks associated with red blood cell transfusion in the trauma population, a meta-analysis. Injury 45 (2014), 1522–1533.
15. Watson, GA, Sperry, JL, Rosengart, MR, et al. Fresh Frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 67 (2009), 221–227.
16. Shorra, AF, Jackson, WL, Transfusion practice and nosocomial infection: assessing the evidence. Curr Opin Crit Care 11 (2005), 468–472.
17. Winearls, J, Reade, M, Miles, H, et al. Targeted coagulation management in severe trauma: the controversies and the evidence. Anesth Analg 123 (2016), 910–923.
18. Yang, L, Stanworth, S, Hopewell, S, Doree, C, Murphy, M, Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 52 (2012), 1673–1686.
19. Desborough, M, Sandu, R, Brunskill, SJ, et al. Fresh frozen plasma for cardiovascular surgery. Cochrane Database Syst Rev, 14, 2015, CD007614.
20. Davenport, R, Curry, N, Manson, J, et al. Frequency and characteristics of coagulopathy in trauma patients treated with a low- or high-plasma-content massive transfusion protocol. J Trauma 70 (2011), 90–96.
21. Khan, S, Brohi, K, Chana, M, et al. Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg 76 (2014), 561–568.
22. Chambers, LA, Chow, SJ, Shaffer, LE, Frequency and characteristics in trauma patients treated with a low or high plasma content massive transfusion protocol. Am J Clin Pathol 136 (2011), 364–370.
23. Rouke, C, Curry, N, Khan, S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 10 (2012), 1342–1351.
24. Fominskiy, E, Nepomniashchikh, VA, Lomivorotov, VV, et al. Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. J Cardiothoracic Vasc Anesth 130 (2016), 1196–1204.
25. Holcomb, JR, del Junco, DJ, Fox, EE, et al. The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 148 (2013), 127–136.
26. Fries, D, Innerhofer, P, Schobersberger, W, Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 22 (2009), 267–274.
27. Rossaint, R, Bouillon, B, Cerny, V, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care, 14, 2010, R52.
28. Mosesson, MW, Update on antithrombin I (fibrin). Thromb Haemost 98 (2007), 105–108.